Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
crisis
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
opioid
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
abbvie
activism
acute hepatic porphyria
adverse events database
africa
alnylam pharmaceuticals
amgen
amunix pharmaceuticals
and save the children.
What
bio
conference
roundup
abbvie’s
advanced
alnylam’s
approval
barbecuing
bff
camping
cardiologist
center
check
cholesterol
company’s
continue
copyright
day
deals
devoted
disease
drug
easl
ebola
facebook’s
flop
form
future
gene
gigaom
gives
good
healthcare
hit
initiative
insight
j
j’s
key
kicked
Language
unset
Current search:
crisis
×
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@gigaom.com
9 years ago
Is Facebook’s Ebola initiative the future of the company’s healthcare strategy?
